GSK plc Q4 2025 Filing

Filed February 12, 2026

Portfolio Value

$799.0M

Holdings

15

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (15 positions)

#StockSharesValue% PortfolioType
1
WVEWAVE LIFE SCIENCES LTD
18,245,691$310.2M38.82%
2
CRSPCRISPR THERAPEUTICS AG
3,220,627$168.9M21.14%
3
BNTXBIONTECH SE
889,824$84.7M10.60%
4
VIRVIR BIOTECHNOLOGY INC
8,550,954$51.6M6.45%
5
LYELLYELL IMMUNOPHARMA INC
1,512,659$46.6M5.83%
6
IDYAIDEAYA BIOSCIENCES INC
1,333,333$46.1M5.77%
7
CYTKCYTOKINETICS INC
340,434$21.6M2.71%
8
SPROSPERO THERAPEUTICS INC
9,190,606$21.4M2.68%
9
FULCFULCRUM THERAPEUTICS INC
1,785,714$20.2M2.53%
10
BCYCBICYCLE THERAPEUTICS PLC
1,529,561$10.8M1.36%
11
CVRXCVRX INC
1,007,583$7.2M0.90%
12
NKTXNKARTA INC
3,150,732$5.8M0.73%
13
RGNXREGENXBIO INC
271,456$3.9M0.49%
14
SENSSENSEONICS HLDGS INC
10,856$59K0.01%
15
HBIOHARVARD BIOSCIENCE INC
11,151$7K0.00%